Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
5(56%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_2
2
22%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Active, not recruiting3
Recruiting2
Completed1
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
N/A5 (62.5%)

Trials by Status

completed111%
terminated111%
withdrawn111%
recruiting222%
unknown111%
active_not_recruiting333%

Recent Activity

5 active trials
Showing 5 of 9
active_not_recruitingphase_2

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

NCT04465500
recruiting

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

NCT07004582
recruitingphase_1

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

NCT03424850
active_not_recruitingnot_applicable

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

NCT03312972
active_not_recruitingnot_applicable

Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer

NCT02560181
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04465500Phase 2

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Active Not Recruiting
NCT07004582

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Recruiting
NCT03424850Phase 1

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Recruiting
NCT03312972Not Applicable

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

Active Not Recruiting
NCT02560181Not Applicable

Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer

Active Not Recruiting
NCT00911079Not Applicable

Pilot Study of a Catheter-based Ultrasound Hyperthermia System

Terminated
NCT02618161Not Applicable

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Completed
NCT02546427Not Applicable

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Withdrawn
NCT02258087Phase 2

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

Unknown

All 9 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
9